Market Access

Podcast: How Accelerated Drug Development Requires Disruption in Market Access and Pricing

Are selective contracts with German insurances a smarter reimbursement pathway, Tim Hering?

Would AI substitute or (only) support market access managers, Dr. Andree Bates?

The UK market access has always been complex, now even more than before, Graham Foxon and Paul Craddy?

AMNOG was the end of paradise for pharmaceutical companies, correct Prof. Hammerschmidt?

Podcast Q&A: Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations

Network meta-analysis and its role in evidence-based decision-making

Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases

Market Access - Transforming BioTech Commercial Decisions?

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Beyond Accelerated Approvals: External Control Arms

Cell & Gene Therapies - Beginning with the End in Mind

Tracking and Measuring Market Access Performance

Medicare Part D: Price Negotiation Panel Discussion

Impact of the 2023 CMS Prior Authorization Rule

Stay Ahead of the Game: Learn How to Conduct an Evidence-Based GVD Faster and Smarter to Improve Market Access

Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data

Expediting drug product development and commercialization in global markets with global filing strategies

How to Unlock Market Access & Pricing Potential of Orphan Drugs

Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval

New Insights into ATMP Valuation and Outcomes-Based Pricing Experience

Make Market Access Your Brand's Super Power - September 21st

US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th

Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations

Become an expert & hone your skills for Pharma, Biotech, Medical & Diagnostic Device launches

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

AMNOG impact on European countries?! Joint webinar with Medvance

Value-Based Agreements - Are We Going to See More or Less of Them?

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

Predicting Payer Uptake with Precision

Weekly News Roundup - Biosimilar Policy Changes, mRNA Leadership Shifts, and Rare Disease Market Growth

Weekly News Roundup - AI Drug Discovery Deals, mRNA Regulatory Setbacks, and Global Investment Shifts

Weekly News Roundup - Regulatory RWE Battles, Capital Market Moves, and Cash-Pay Drug Pricing Disruption

INsights & OUTcomes with Taylor Hirschberg

Weekly News Roundup - Oral GLP-1 Momentum, Trade Tensions, EU Drug Security, and AI Risk Warnings

Weekly News Roundup - Neurodegeneration Deals, Generative AI, and Drug Pricing Politics

Weekly News Roundup - Tariff-Free Pharma, Biologics Modernization, Duchenne Trial Success, and Maternal Health Advances

Weekly News Roundup - Four Big Moves in Medtech, Neurotech, Biopharma R&D & Pharma M&A

Weekly News Roundup - CAR-T Safety Alerts, Policy Ripple Effects, and Notable Wearables

Weekly News Roundup - Immunology, Innovation, and Impact

Weekly News Roundup - Medicaid Deals, Oncology Innovation, and Market Tensions Abroad

Weekly News Roundup - Public Health Flashpoints, Pharma Innovation, and Pricing Battles

Weekly News Roundup - Vaccine Policy Shifts, AI-Powered R&D, and Billion-Dollar Investments

Weekly News Roundup - Pharma Acquisitions, Trial Triumphs, and Coding Controversies

Weekly News Roundup - Obesity Drug Rivalry, Rare Disease Pathways, Vaccine Mandate Battles, and ACA Shake-Ups

Weekly News Roundup - Ransomware Shocks, Vaccine Policy Shifts, and Billion-Dollar Pharma Investments

Weekly News Roundup - Alzheimer's Breakthroughs, Cancer Trial Advances, and High-Stakes Policy Battles

Weekly News Roundup - Pharmacist Empowerment, Financial Shifts, and Innovative Health Solutions

Weekly News Roundup - Pharma Pilots, Legal Battles, and Precision Medicine Breakthroughs

Weekly News Roundup - Vaccine Triumphs, Revolutionary Trials, and Data-Driven Health Futures

Meeting the Resource Challenge - Why Biotechs Need a Different Kind of Partner

INsights & OUTcomes with Matt McLoughlin

INsights & OUTcomes with Rosa Willock

INsights & OUTcomes with Chris O'Neill

Podcast Q&A: EU HTA Joint Clinical Assessments

Podcast Q&A: Medicare and Medicaid Services Market Pricing

Podcast Q&A: Literature Reviews and Global Value Dossiers

Podcast Q&A: Discussing Health Technology Assessment Agencies

Podcast Q&A: Platforms and Models for Payer Insights and Evidence Generation